Desoximetasone 0.25% spray

DRUG2 trials

Sponsors

Sun Pharmaceutical Industries, Inc., Wake Forest University Health Sciences

Conditions

Atopic DermatitisPsoriasis

Phase 2

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

CompletedNCT01043393

Sun Pharmaceutical Industries, Inc.Psoriasis

Start: 2010-02-28End: 2010-06-30Updated: 2014-06-02

Phase 4

Evaluating Treatment Resistant Dermatitis TaroIIR

CompletedNCT03050294

Wake Forest University Health SciencesAtopic Dermatitis, Psoriasis

Start: 2017-02-01End: 2017-06-01Updated: 2020-05-20